+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-acting tranquilizer-anticholinergic in gastrointestinal disorders: an experimental and clinical study



Long-acting tranquilizer-anticholinergic in gastrointestinal disorders: an experimental and clinical study



American Journal of Gastroenterology 33: 73-79




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049489368

Download citation: RISBibTeXText

PMID: 13806207


Related references

Clinical experience with anticholinergic-tranquilizer in gastrointestinal disorders. Clinical Medicine 69: 859 Passim, 1962

A Long Acting Anticholinergic-Sedative Combination in Gastrointestinal Disorders. Clinical Trial of Oxyphencyclimine Hydrochloride with Phenobarbital (Daricon Pb). Journal of the National Medical Association 56: 244-247, 1964

Controlled clinical study of a new combination of a tranquilizer and an anticholinergic drug in various gastrointestinal diseases. Minerva Dietologica E Gastroenterologica 25(1): 33-40, 1979

Treatment of gastrointestinal disorders with an anticholinergic tranquilizer combination. Journal of the Medical Association of Georgia 48(5): 218-220, 1959

Tranquilizer anticholinergic therapy in functional gastrointestinal disorders. Applied Therapeutics 4: 828-9 Passim, 1962

Clinical Trial of Fluphenazine Enanthate-- a Long-Acting Injectable Tranquilizer. American Journal of Psychiatry 121: 73-74, 1964

The clinical evaluation of a new long-acting anticholinergic drug. American Journal of Gastroenterology 34: 179-182, 1960

Clinical evaluation of three long-acting anticholinergic compounds. Gut 9(5): 590-596, 1968

Clinical experience with a new long-acting ant-acid-anticholinergic preparation. American Journal of Gastroenterology 32: 509-517, 1959

Compare the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease. Tuberkuloz Ve Toraks 64(2): 112-118, 2017

Clinical results in patients with various gastrointestinal disorders treated with a new anticholinergic. New York State Journal of Medicine 57(13): 2214-2219, 1957

Clinical and experimental observations in peptic ulcer with a new, prolonged-acting anticholinergic drug. American Journal of Gastroenterology 29(6): 585-92; Discussion 592-5, 1958

A clinical evaluation of a new anticholinergic-antacid combination in the treatment of gastrointestinal disorders. American Journal of Gastroenterology 30(6): 618-623, 1958

Maintenance therapy in gastrointestinal disorders; 18-month study of a new anticholinergic. American Journal of Gastroenterology 32: 370-374, 1959

Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 125(5): 307-313, 2005